Guardant Health to Participate Virtually in the 40th Annual J.P. Morgan Healthcare Conference

Rhea-AI Summary

Guardant Health, a leader in precision oncology, announced its participation in the 40th Annual J.P. Morgan Healthcare Conference. The presentation will occur on January 10 at 12:00 p.m. PT / 3:00 p.m. ET. Investors can access the live and archived webcast through the company’s website. Guardant Health focuses on combating cancer using proprietary tests, including Guardant360® and Guardant Reveal™, aiming to improve outcomes and reduce healthcare costs across the cancer care continuum.

REDWOOD CITY, Calif.--(BUSINESS WIRE)-- Guardant Health, Inc. (Nasdaq: GH), a leading precision oncology company, today announced the company will be participating in the upcoming 40th Annual J.P. Morgan Healthcare Conference.

Guardant Health’s management is scheduled to present on Monday, January 10 at 12:00 p.m. Pacific Time / 3:00 p.m. Eastern Time. Interested parties may access a live and archived webcast of the presentation on the “Investors” section of the company website at: www.guardanthealth.com.

About Guardant Health

Guardant Health is a leading precision oncology company focused on helping conquer cancer globally through use of its proprietary tests, vast data sets and advanced analytics. The Guardant Health oncology platform leverages capabilities to drive commercial adoption, improve patient clinical outcomes and lower healthcare costs across all stages of the cancer care continuum. Guardant Health has commercially launched Guardant360®, Guardant360 CDx, Guardant360 TissueNext™, Guardant360 Response™, and GuardantOMNI® tests for advanced stage cancer patients, and Guardant Reveal™ for early-stage cancer patients. These tests fuel development of its LUNAR screening program, which aims to address the needs of asymptomatic individuals eligible for cancer screening.

View source version on businesswire.com: https://www.businesswire.com/news/home/20211229005020/en/

Investor Contact:

Carrie Mendivil

investors@guardanthealth.com

Media Contact:

Michele Rest

press@guardanthealth.com

Source: Guardant Health, Inc.

FAQ

What date is Guardant Health presenting at the J.P. Morgan Healthcare Conference?

Guardant Health will present on January 10 at 12:00 p.m. Pacific Time.

What time is the Guardant Health presentation in Eastern Time?

The presentation will be at 3:00 p.m. Eastern Time.

How can I watch Guardant Health's conference presentation?

You can access the live and archived webcast on Guardant Health’s official website.

What is the focus of Guardant Health's oncology platform?

Guardant Health's oncology platform focuses on improving patient outcomes and reducing healthcare costs through advanced cancer testing.

What are some tests launched by Guardant Health?

Guardant Health has launched tests such as Guardant360®, Guardant Reveal™, and others for various stages of cancer.